QLT (QLTI)
QLT Cash and ST Investments: 207.19M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
QLTI Cash and ST Investments Rankings
| Overall | 68th percentile | 1388 of 4370 |
| Sector | 78th percentile | 109 of 506 in Healthcare |
| Industry | 81st percentile | 30 of 160 in Biotechnology |
QLTI Cash and ST Investments Range, Past 5 Years
| Minimum | 134.92M | Jun 2009 |
| Maximum | 294.21M | Sep 2007 |
| Average | 223.30M |
About Cash and Short Term Investments
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities
Learn More
You may also be interested in these QLTI related companies
QLTI News
QLT Inc. (QLTI) Indicated Higher; Shareholder Axial Capital May Be in Discussion w/ Management
May 25, 6:42AM Street Insider
May 25, 6:42AM Street Insider
QLT Inc. (QLTI) Announces Board Will Propose $75-$100M Dutch Auction Tender Offer
May 24, 4:29PM Street Insider
May 24, 4:29PM Street Insider
QLT Inc. (QLTI) Issues Response to Nordic Biotech Notification on Board Nominees
May 23, 8:57AM Street Insider
May 23, 8:57AM Street Insider
QLT Inc. (QLTI) Says Nordic Biotech to Vote 7.4M Common in Favor of Nominees
May 23, 8:56AM Street Insider
May 23, 8:56AM Street Insider
QLT Announces Notification of Legal Proxy Action in Advance of Annual Meeting of Stockholders
May 23, 6:30AM GlobeNewswire
May 23, 6:30AM GlobeNewswire
$QLTI Insider Buy: $333K of stock bought by Florian Schonharting on May 16, 2012 http://stks.co/3tlU
about 14 days ago by MarketBrief
about 14 days ago by MarketBrief
Media Advisory: QLT to Report First Quarter Financial Results on May 3, 2012
Apr 19, 6:30AM GlobeNewswire
Apr 19, 6:30AM GlobeNewswire
QLT Announces the Appointment of Christopher Muller as Chief Commercial Officer
Apr 16, 6:30AM GlobeNewswire
Apr 16, 6:30AM GlobeNewswire
QLT's CEO Presents at 30th Annual JPMorgan Healthcare Conference - Conference Call Transcript
Mar 09, 2:46PM Seeking Alpha
Mar 09, 2:46PM Seeking Alpha
Media Advisory: QLT to Present at ROTH Capital Partners Annual Growth Stock Conference
Mar 08, 6:30AM GlobeNewswire
Mar 08, 6:30AM GlobeNewswire
QLT Inc. (QLTI) Reports Positive Preliminary Results From Phase 1b Trial of QLT091001
Mar 01, 6:52AM Street Insider
Mar 01, 6:52AM Street Insider
Media Advisory: QLT to Present at the 2012 RBC Capital Markets' Global Healthcare Conference
Feb 23, 4:10PM GlobeNewswire
Feb 23, 4:10PM GlobeNewswire
$QLTI http://stks.co/2TBv having exited from high and tight flag on daily
about 104 days ago by traderdigs
about 104 days ago by traderdigs
$QLTI http://stks.co/2TBt bit late but wanted to pt out nice xo for this flu stock in 30min @adxguy
about 104 days ago by traderdigs
about 104 days ago by traderdigs
Media Advisory: QLT to Report 2011 Fourth Quarter and Year End Financial Results on February 23, 2012
Feb 16, 4:10PM GlobeNewswire
Feb 16, 4:10PM GlobeNewswire
5 Small Cap Health Services Stocks To Watch http://stks.co/2Mka $BIOS $EXAM $MRGE $QLTI $ZIOP
about 109 days ago by waterburyresearch
about 109 days ago by waterburyresearch
Media Advisory: QLT to Present at the Leerink Swann 2012 Global Healthcare Conference
Feb 08, 6:30AM GlobeNewswire
Feb 08, 6:30AM GlobeNewswire
MEDIA ADVISORY: QLT to Present at the J.P. Morgan Healthcare Conference
Jan 09, 6:30AM GlobeNewswire
Jan 09, 6:30AM GlobeNewswire
$QLTI 200 Day SMA Cross - Price crossed above 200 day SMA (7.0748). Confirmed by volume.
about 163 days ago by TradeIdeasQuant
about 163 days ago by TradeIdeasQuant
Media Advisory: QLT to Host Research and Development Day in New York City on December 16, 2011
Dec 08, 6:30AM GlobeNewswire
Dec 08, 6:30AM GlobeNewswire
$QLTI $6.91 CLARKE C BOYD director P 4,000 @ $6.75 amnt $27,000 proc'd $640 6/17/2011
about 346 days ago by canarionyc
about 346 days ago by canarionyc
$QLTI http://chart.ly/agvcvi5 Flag #Pattern BO, T~$8+ inside CnH Pattern, T~$9.5; Bullish $Flow; #Wave C, T~$9.6; Long Jul calls
about 366 days ago by RatioCynic
about 366 days ago by RatioCynic
$QLTI treatment of eye disease w/ ocular drugs/devices: retinal, glaucoma, ocular hypertension-increasing probs of aging boomer population
about 420 days ago by abubnic
about 420 days ago by abubnic
$QLTI coverage initiated with "outperform" at Leerink. Target: $12-$13/share.
about 420 days ago by abubnic
about 420 days ago by abubnic
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| QLTI | 7.61 | +0.03 | +0.40% | 371.12M |
| QLT | 23.95 | +0.23 | +0.97% | |
| QLIK | 22.73 | -0.40 | -1.73% | 1.954B |
| QLGC | 13.61 | -0.20 | -1.45% | 1.363B |
| QLD | 49.87 | -0.43 | -0.85% | |
| QIHU | 20.00 | -0.53 | -2.58% | 702.54M |
| QID | 35.26 | +0.30 | +0.86% | |
| QGEN | 16.00 | -0.25 | -1.54% | 3.806B |
| QEP | 26.32 | +0.15 | +0.57% | 4.645B |
| QDEL | 15.72 | +0.18 | +1.16% | 513.91M |
